David Hamerman

4.5k total citations · 1 hit paper
103 papers, 3.6k citations indexed

About

David Hamerman is a scholar working on Molecular Biology, Rheumatology and Cell Biology. According to data from OpenAlex, David Hamerman has authored 103 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 24 papers in Rheumatology and 22 papers in Cell Biology. Recurrent topics in David Hamerman's work include Proteoglycans and glycosaminoglycans research (19 papers), Osteoarthritis Treatment and Mechanisms (16 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). David Hamerman is often cited by papers focused on Proteoglycans and glycosaminoglycans research (19 papers), Osteoarthritis Treatment and Mechanisms (16 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). David Hamerman collaborates with scholars based in United States, United Kingdom and Kenya. David Hamerman's co-authors include Peter Barland, Alex B. Novikoff, Maxwell Schubert, Franklin H. Epstein, John Sandson, David D. Wood, Rosamond Janis, Earl J. Ihrie, Carol A. Smith and Jonas H. Sirota and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David Hamerman

99 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ELECTRON MICROSCOPY OF THE HUMAN SYNOVIAL MEMBRANE

1962 440 citations David Hamerman et al. profile →

Peers

David Hamerman

RHEUM

MB

CB

SURGE

IA

George E. Ehrlich United States

Richard A. Berg United States

Kusuki Nishioka Japan

Yu‐Tsan Lin Taiwan

Dan Caspi Israel

L Juhlin Sweden

Stephen F. Kemp United States

Mats Jontell Sweden

Neal S. Fedarko United States

J.L. Burton United Kingdom

George E. Ehrlich United States

David Hamerman

1.9k ×1.6

RHEUM

710 ×0.9

MB

156 ×0.2

CB

884 ×1.9

SURGE

184 ×0.4

IA

Citations per year, relative to David Hamerman David Hamerman (= 1×) peers George E. Ehrlich

Countries citing papers authored by David Hamerman

Since Specialization

Citations

This map shows the geographic impact of David Hamerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hamerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hamerman more than expected).

Fields of papers citing papers by David Hamerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hamerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hamerman. The network helps show where David Hamerman may publish in the future.

Co-authorship network of co-authors of David Hamerman

This figure shows the co-authorship network connecting the top 25 collaborators of David Hamerman. A scholar is included among the top collaborators of David Hamerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hamerman. David Hamerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hamerman, David. (2005). Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM. 98(7). 467–484. 115 indexed citations

2.

Hamerman, David. (2004). Bone health across the generations: a primer for health providers concerned with osteoporosis prevention. Maturitas. 50(1). 1–7. 6 indexed citations

3.

Haramati, Linda B., et al.. (2003). Evaluation of Vertebral Fractures on Lateral Chest Radiographs of Inner-City Postmenopausal Women. Calcified Tissue International. 73(6). 550–554. 27 indexed citations

4.

Hamerman, David. (2002). Molecular-Based Therapeutic Approaches in Treatment of Anorexia of Aging and Cancer Cachexia. The Journals of Gerontology Series A. 57(8). M511–M518. 27 indexed citations

5.

Hamerman, David, et al.. (2001). Translating basic aging research into geriatric health care. Experimental Gerontology. 36(2). 193–203. 4 indexed citations

6.

Hamerman, David. (2000). Considerations of osteoporosis prevention in an aging society. Maturitas. 37(2). 69–73. 7 indexed citations

7.

Hamerman, David. (1997). Osteoarthritis : public health implications for an aging population. Johns Hopkins University Press eBooks. 14 indexed citations

8.

Hamerman, David. (1997). Aging and the musculoskeletal system. Annals of the Rheumatic Diseases. 56(10). 578–585. 23 indexed citations

9.

Hamerman, David. (1995). Clinical implications of osteoarthritis and ageing.. Annals of the Rheumatic Diseases. 54(2). 82–85. 62 indexed citations

10.

Hamerman, David. (1993). Aging and Osteoarthritis: Basic Mechanisms. Journal of the American Geriatrics Society. 41(7). 760–770. 58 indexed citations

11.

Hamerman, David, et al.. (1992). Responses of the Health Professions to the Demographic Revolution: A Multidisciplinary Perspective. Perspectives in biology and medicine. 35(4). 583–593. 2 indexed citations

12.

Epstein, Franklin H. & David Hamerman. (1989). The Biology of Osteoarthritis. New England Journal of Medicine. 320(20). 1322–1330. 253 indexed citations

13.

Damus, Karla, et al.. (1988). Risk Factors Associated with Immobility. Journal of the American Geriatrics Society. 36(8). 707–712. 50 indexed citations

14.

Hamerman, David, Samuel J. Taylor, Michael Klagsbrun, et al.. (1987). Growth Factors With Heparin Binding Affinity In Human Synovial Fluid. Experimental Biology and Medicine. 186(3). 384–389. 32 indexed citations

15.

Hamerman, David, et al.. (1982). Glycosaminoglycans Produced by Human Synovial Cell Cultures. Collagen and Related Research. 2(4). 313–329. 41 indexed citations

16.

Smith, Catherine, Edward T. Habermann, & David Hamerman. (1979). A technique for investigating the antigenicity of cultured rheumatoid synovial cells.. PubMed. 6(2). 147–55. 3 indexed citations

17.

Hamerman, David. (1974). Attending-physician--house-staff interactions on a private medical service. Academic Medicine. 49(6). 570–4. 2 indexed citations

18.

Smith, C.A. & David Hamerman. (1968). Resistance of rheumatoid synovial cells to infection with exogenous virus abstract component newcastle disease virus. Arthritis & Rheumatism. 11(6). 842. 10 indexed citations

19.

Schubert, Maxwell & David Hamerman. (1968). A primer on connective tissue biochemistry. 53 indexed citations

20.

Hamerman, David, et al.. (1959). Histologic studies on human synovial membrane. 2. Localization of some oxidative enzymes in synovial membrane cells. Arthritis & Rheumatism. 2(6). 553–558. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact